Global Alliance for TB Drug Development | ClinicalTrials HQ

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Sorfequiline-based Regimens in Adults With Newly Diagnosed Drug-sensitive Pulmonary TB	Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, lung disorder, mycobacterial infectious disease, pulmonary tuberculosis, respiratory system disorder, respiratory tract infectious disorder, tuberculosis	Recruiting	Phase 2	2026-08-19		NCT07672405
Telacebec (T) Treatment in Adults With Buruli Ulcer (BU). (TREAT BU)	Actinomycetales infectious disease, Bacterial Infections and Mycoses, Buruli ulcer disease, Infections, Mycobacterium Infections, Nontuberculous, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin Ulcer, Skin and Connective Tissue Diseases, bacterial infectious disease, gram-positive bacterial infections, mycobacterial infectious disease, skin disorder, ulcer disease	Recruiting	Phase 2	2026-06-30		NCT06481163
Phase 2 Trial Assessing TBAJ876 or Bedaquiline, With Pretomanid and Linezolid in Adults With Drug-sensitive Pulmonary Tuberculosis	Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, lung disorder, mycobacterial infectious disease, pulmonary tuberculosis, respiratory system disorder, respiratory tract infectious disorder, tuberculosis	Active, not recruiting	Phase 2	2026-06-24		NCT06058299
A Pan-TB Regimen Targeting Host and Microbe	Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, mycobacterial infectious disease, tuberculosis	Active, not recruiting	Phase 2 / Phase 3	2025-05-28		NCT05686356